Suíça - francês - Swissmedic (Swiss Agency for Therapeutic Products)

ibsa institut biochimique sa - natrii hyaluronas, sulfadiazinum argenticum - crème - natrii hyaluronas 2 mg, sulfadiazinum argenticum 10 mg, laurilsulfas, excipiens ad pommade pour 1 g de la. - le traitement des ulcères, des plaies et des brûlures infectées - biotechnologika

Suíça - francês - Swissmedic (Swiss Agency for Therapeutic Products)

b.e.imaging.ag - natrii iodidum(123-i) - solution injectable - natrii iodidum(123-i) 37 mbq, natrii chloridum, natrii hydrogenocarbonas, aqua ad iniectabile q.s. ad solutionem pro 1 ml corresp. natrium 3.6 mg. - schilddrüsendiagnostik; pour le marquage de produits radiopharmaceutiques - radiopharmazeutika

Suíça - francês - Swissmedic (Swiss Agency for Therapeutic Products)

sandoz pharmaceuticals ag - natrii cromoglicas - sandoz - natrii cromoglicas 20 mg, natrii chloridum, dinatrii edetas, sorbitolum, natrii dihydrogenophosphas dihydricus 1 mg et dinatrii phosphas dodecahydricus 5 mg corresp. phosphas 1.94 mg, aqua ad iniectabilia, ad solutionem pro 1 ml. - la conjonctivite allergique - synthetika

Suíça - francês - Swissmedic (Swiss Agency for Therapeutic Products)

ibsa institut biochimique sa - natrii hyaluronas - crème nasale - natrii hyaluronas 2 mg, macrogoli 8 stearas typus i, decylis oleas, alcohol cetylicus et stearylicus 20 mg, natrii laurilsulfas 1 mg, natrii cetylo- et stearylosulfas, glycerolum, sorbitolum liquidum non cristallisabile, natrii dehydroacetas, e 218 2 mg, propylis parahydroxybenzoas 0.2 mg, aqua purificata, ad unguentum pro 1 g. - le traitement de la sécheresse de la muqueuse nasale - synthetika

Suíça - francês - Swissmedic (Swiss Agency for Therapeutic Products)

desitin pharma gmbh - natrii valproas - solution injectable - natrii valproas 300 mg, dinatrii edetas, aqua ad iniectabile q.s. ad solutionem pro 3 ml. - antiepileptikum - synthetika

Suíça - francês - Swissmedic (Swiss Agency for Therapeutic Products)

future health pharma gmbh - natrii risedronas - comprimés pelliculés - natrii risedronas 5 mg, excipiens pro compresso obducto. - osteoporose, paget-krankheit - synthetika

Suíça - francês - Swissmedic (Swiss Agency for Therapeutic Products)

future health pharma gmbh - natrii risedronas - comprimés pelliculés - natrii risedronas 30.0 mg corresp. natrium 2.26 mg, lactosum monohydricum 131.0 mg, cellulosum microcristallinum, crospovidonum, magnesii stearas, Überzug: hypromellosum, macrogolum 400, hydroxypropylcellulosum, macrogolum 8000, silica colloidalis anhydrica, e 171, pro compresso obducto. - osteoporose, paget-krankheit - synthetika

Suíça - francês - Swissmedic (Swiss Agency for Therapeutic Products)

future health pharma gmbh - natrii risedronas - comprimés pelliculés - natrii risedronas 35.0 mg corresp. natrium 2.64 mg, lactosum monohydricum 126.0 mg, cellulosum microcristallinum, crospovidonum, magnesii stearas, Überzug: hypromellosum, macrogolum 400, hydroxypropylcellulosum, macrogolum 8000, silica colloidalis anhydrica, e 171, e 172 (flavum), e 172 (rubrum), pro compresso obducto. - osteoporose, paget-krankheit - synthetika

Suíça - francês - Swissmedic (Swiss Agency for Therapeutic Products)

amino ag, fabrikation pharmazeutischer und chemischer produkte - natrii chloridum - solution injectable - natrii chloridum 9 mg, aqua ad iniectabile q.s. ad solutionem pro 1 ml corresp. natrium 154 mmol, chloridum 154 mmol/l. - liquide de dilution - synthetika

Suíça - francês - Swissmedic (Swiss Agency for Therapeutic Products)

sintetica sa - natrii hydrogenocarbonas - la solution injectable - natrii hydrogenocarbonas 84 mg, aqua ad iniectabile q.s. ad solutionem pro 1 ml corresp. hydrogenocarbonas 1 mmol, natrium 1 mmol. - le traitement de l'acidose - synthetika